Search results for abx831576

Teplizumab, Abbexa, abx831576

Teplizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. This is anti-CD3 monoclonal antibody that is used in high-risk groups to prevent or delay the development of clinical type 1 diabetes (T1D). High-risk groups here refer to the presence of two or more T1D-related autoantibodies in the body.